Global Neurological Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Neurological Drugs market size was valued at USD 121420 million in 2022 and is forecast to a readjusted size of USD 196010 million by 2029 with a CAGR of 7.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report is a detailed and comprehensive analysis for global Neurological Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurological Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis, Mylan and Randox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neurological Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Neurological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Drugs, with price, sales, revenue and global market share of Neurological Drugs from 2018 to 2023.
Chapter 3, the Neurological Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurological Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Drugs.
Chapter 14 and 15, to describe Neurological Drugs sales channel, distributors, customers, research findings and conclusion.
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report is a detailed and comprehensive analysis for global Neurological Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurological Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Neurological Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurological Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis, Mylan and Randox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neurological Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Non-prescription drugs
- Prescription
- Hospital
- Clinic
- Pfizer
- Ely Lilly
- Actavis
- Mylan
- Randox
- Intellipharmaceutics
- Astrazeneca
- Lundbeck
- Allergan
- GSK
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- North China Pharmaceutical
- Harbin Pharmaceutical Co., Ltd.
- Lukang Pharmaceutical
- Kelun Pharmaceutical
- Kehua Biology
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Neurological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurological Drugs, with price, sales, revenue and global market share of Neurological Drugs from 2018 to 2023.
Chapter 3, the Neurological Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neurological Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Drugs.
Chapter 14 and 15, to describe Neurological Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neurological Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neurological Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Non-prescription drugs
1.3.3 Prescription
1.4 Market Analysis by Application
1.4.1 Overview: Global Neurological Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Neurological Drugs Market Size & Forecast
1.5.1 Global Neurological Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neurological Drugs Sales Quantity (2018-2029)
1.5.3 Global Neurological Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Neurological Drugs Product and Services
2.1.4 Pfizer Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Ely Lilly
2.2.1 Ely Lilly Details
2.2.2 Ely Lilly Major Business
2.2.3 Ely Lilly Neurological Drugs Product and Services
2.2.4 Ely Lilly Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ely Lilly Recent Developments/Updates
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Neurological Drugs Product and Services
2.3.4 Actavis Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Actavis Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Neurological Drugs Product and Services
2.4.4 Mylan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Randox
2.5.1 Randox Details
2.5.2 Randox Major Business
2.5.3 Randox Neurological Drugs Product and Services
2.5.4 Randox Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Randox Recent Developments/Updates
2.6 Intellipharmaceutics
2.6.1 Intellipharmaceutics Details
2.6.2 Intellipharmaceutics Major Business
2.6.3 Intellipharmaceutics Neurological Drugs Product and Services
2.6.4 Intellipharmaceutics Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Intellipharmaceutics Recent Developments/Updates
2.7 Astrazeneca
2.7.1 Astrazeneca Details
2.7.2 Astrazeneca Major Business
2.7.3 Astrazeneca Neurological Drugs Product and Services
2.7.4 Astrazeneca Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astrazeneca Recent Developments/Updates
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Neurological Drugs Product and Services
2.8.4 Lundbeck Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lundbeck Recent Developments/Updates
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Neurological Drugs Product and Services
2.9.4 Allergan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Neurological Drugs Product and Services
2.10.4 GSK Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Otsuka Pharmaceutical
2.11.1 Otsuka Pharmaceutical Details
2.11.2 Otsuka Pharmaceutical Major Business
2.11.3 Otsuka Pharmaceutical Neurological Drugs Product and Services
2.11.4 Otsuka Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Otsuka Pharmaceutical Recent Developments/Updates
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Neurological Drugs Product and Services
2.12.4 Takeda Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Takeda Recent Developments/Updates
2.13 NHU Group
2.13.1 NHU Group Details
2.13.2 NHU Group Major Business
2.13.3 NHU Group Neurological Drugs Product and Services
2.13.4 NHU Group Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NHU Group Recent Developments/Updates
2.14 Shionogi
2.14.1 Shionogi Details
2.14.2 Shionogi Major Business
2.14.3 Shionogi Neurological Drugs Product and Services
2.14.4 Shionogi Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shionogi Recent Developments/Updates
2.15 APOTEX
2.15.1 APOTEX Details
2.15.2 APOTEX Major Business
2.15.3 APOTEX Neurological Drugs Product and Services
2.15.4 APOTEX Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 APOTEX Recent Developments/Updates
2.16 North China Pharmaceutical
2.16.1 North China Pharmaceutical Details
2.16.2 North China Pharmaceutical Major Business
2.16.3 North China Pharmaceutical Neurological Drugs Product and Services
2.16.4 North China Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 North China Pharmaceutical Recent Developments/Updates
2.17 Harbin Pharmaceutical Co., Ltd.
2.17.1 Harbin Pharmaceutical Co., Ltd. Details
2.17.2 Harbin Pharmaceutical Co., Ltd. Major Business
2.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
2.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Lukang Pharmaceutical
2.18.1 Lukang Pharmaceutical Details
2.18.2 Lukang Pharmaceutical Major Business
2.18.3 Lukang Pharmaceutical Neurological Drugs Product and Services
2.18.4 Lukang Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Lukang Pharmaceutical Recent Developments/Updates
2.19 Kelun Pharmaceutical
2.19.1 Kelun Pharmaceutical Details
2.19.2 Kelun Pharmaceutical Major Business
2.19.3 Kelun Pharmaceutical Neurological Drugs Product and Services
2.19.4 Kelun Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Kelun Pharmaceutical Recent Developments/Updates
2.20 Kehua Biology
2.20.1 Kehua Biology Details
2.20.2 Kehua Biology Major Business
2.20.3 Kehua Biology Neurological Drugs Product and Services
2.20.4 Kehua Biology Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Kehua Biology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEUROLOGICAL DRUGS BY MANUFACTURER
3.1 Global Neurological Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neurological Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Neurological Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neurological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neurological Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Neurological Drugs Manufacturer Market Share in 2022
3.5 Neurological Drugs Market: Overall Company Footprint Analysis
3.5.1 Neurological Drugs Market: Region Footprint
3.5.2 Neurological Drugs Market: Company Product Type Footprint
3.5.3 Neurological Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Neurological Drugs Market Size by Region
4.1.1 Global Neurological Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Neurological Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Neurological Drugs Average Price by Region (2018-2029)
4.2 North America Neurological Drugs Consumption Value (2018-2029)
4.3 Europe Neurological Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Neurological Drugs Consumption Value (2018-2029)
4.5 South America Neurological Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Neurological Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Neurological Drugs Sales Quantity by Type (2018-2029)
5.2 Global Neurological Drugs Consumption Value by Type (2018-2029)
5.3 Global Neurological Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neurological Drugs Sales Quantity by Application (2018-2029)
6.2 Global Neurological Drugs Consumption Value by Application (2018-2029)
6.3 Global Neurological Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Neurological Drugs Sales Quantity by Type (2018-2029)
7.2 North America Neurological Drugs Sales Quantity by Application (2018-2029)
7.3 North America Neurological Drugs Market Size by Country
7.3.1 North America Neurological Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Neurological Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Neurological Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Neurological Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Neurological Drugs Market Size by Country
8.3.1 Europe Neurological Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Neurological Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Neurological Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neurological Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neurological Drugs Market Size by Region
9.3.1 Asia-Pacific Neurological Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neurological Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Neurological Drugs Sales Quantity by Type (2018-2029)
10.2 South America Neurological Drugs Sales Quantity by Application (2018-2029)
10.3 South America Neurological Drugs Market Size by Country
10.3.1 South America Neurological Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Neurological Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Neurological Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neurological Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neurological Drugs Market Size by Country
11.3.1 Middle East & Africa Neurological Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neurological Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Neurological Drugs Market Drivers
12.2 Neurological Drugs Market Restraints
12.3 Neurological Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Neurological Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurological Drugs
13.3 Neurological Drugs Production Process
13.4 Neurological Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurological Drugs Typical Distributors
14.3 Neurological Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Neurological Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neurological Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Non-prescription drugs
1.3.3 Prescription
1.4 Market Analysis by Application
1.4.1 Overview: Global Neurological Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Neurological Drugs Market Size & Forecast
1.5.1 Global Neurological Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neurological Drugs Sales Quantity (2018-2029)
1.5.3 Global Neurological Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Neurological Drugs Product and Services
2.1.4 Pfizer Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Ely Lilly
2.2.1 Ely Lilly Details
2.2.2 Ely Lilly Major Business
2.2.3 Ely Lilly Neurological Drugs Product and Services
2.2.4 Ely Lilly Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ely Lilly Recent Developments/Updates
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Neurological Drugs Product and Services
2.3.4 Actavis Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Actavis Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Neurological Drugs Product and Services
2.4.4 Mylan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Randox
2.5.1 Randox Details
2.5.2 Randox Major Business
2.5.3 Randox Neurological Drugs Product and Services
2.5.4 Randox Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Randox Recent Developments/Updates
2.6 Intellipharmaceutics
2.6.1 Intellipharmaceutics Details
2.6.2 Intellipharmaceutics Major Business
2.6.3 Intellipharmaceutics Neurological Drugs Product and Services
2.6.4 Intellipharmaceutics Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Intellipharmaceutics Recent Developments/Updates
2.7 Astrazeneca
2.7.1 Astrazeneca Details
2.7.2 Astrazeneca Major Business
2.7.3 Astrazeneca Neurological Drugs Product and Services
2.7.4 Astrazeneca Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astrazeneca Recent Developments/Updates
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Neurological Drugs Product and Services
2.8.4 Lundbeck Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lundbeck Recent Developments/Updates
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Neurological Drugs Product and Services
2.9.4 Allergan Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Neurological Drugs Product and Services
2.10.4 GSK Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Otsuka Pharmaceutical
2.11.1 Otsuka Pharmaceutical Details
2.11.2 Otsuka Pharmaceutical Major Business
2.11.3 Otsuka Pharmaceutical Neurological Drugs Product and Services
2.11.4 Otsuka Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Otsuka Pharmaceutical Recent Developments/Updates
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Neurological Drugs Product and Services
2.12.4 Takeda Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Takeda Recent Developments/Updates
2.13 NHU Group
2.13.1 NHU Group Details
2.13.2 NHU Group Major Business
2.13.3 NHU Group Neurological Drugs Product and Services
2.13.4 NHU Group Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NHU Group Recent Developments/Updates
2.14 Shionogi
2.14.1 Shionogi Details
2.14.2 Shionogi Major Business
2.14.3 Shionogi Neurological Drugs Product and Services
2.14.4 Shionogi Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shionogi Recent Developments/Updates
2.15 APOTEX
2.15.1 APOTEX Details
2.15.2 APOTEX Major Business
2.15.3 APOTEX Neurological Drugs Product and Services
2.15.4 APOTEX Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 APOTEX Recent Developments/Updates
2.16 North China Pharmaceutical
2.16.1 North China Pharmaceutical Details
2.16.2 North China Pharmaceutical Major Business
2.16.3 North China Pharmaceutical Neurological Drugs Product and Services
2.16.4 North China Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 North China Pharmaceutical Recent Developments/Updates
2.17 Harbin Pharmaceutical Co., Ltd.
2.17.1 Harbin Pharmaceutical Co., Ltd. Details
2.17.2 Harbin Pharmaceutical Co., Ltd. Major Business
2.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
2.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Lukang Pharmaceutical
2.18.1 Lukang Pharmaceutical Details
2.18.2 Lukang Pharmaceutical Major Business
2.18.3 Lukang Pharmaceutical Neurological Drugs Product and Services
2.18.4 Lukang Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Lukang Pharmaceutical Recent Developments/Updates
2.19 Kelun Pharmaceutical
2.19.1 Kelun Pharmaceutical Details
2.19.2 Kelun Pharmaceutical Major Business
2.19.3 Kelun Pharmaceutical Neurological Drugs Product and Services
2.19.4 Kelun Pharmaceutical Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Kelun Pharmaceutical Recent Developments/Updates
2.20 Kehua Biology
2.20.1 Kehua Biology Details
2.20.2 Kehua Biology Major Business
2.20.3 Kehua Biology Neurological Drugs Product and Services
2.20.4 Kehua Biology Neurological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Kehua Biology Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEUROLOGICAL DRUGS BY MANUFACTURER
3.1 Global Neurological Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neurological Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Neurological Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neurological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neurological Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Neurological Drugs Manufacturer Market Share in 2022
3.5 Neurological Drugs Market: Overall Company Footprint Analysis
3.5.1 Neurological Drugs Market: Region Footprint
3.5.2 Neurological Drugs Market: Company Product Type Footprint
3.5.3 Neurological Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Neurological Drugs Market Size by Region
4.1.1 Global Neurological Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Neurological Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Neurological Drugs Average Price by Region (2018-2029)
4.2 North America Neurological Drugs Consumption Value (2018-2029)
4.3 Europe Neurological Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Neurological Drugs Consumption Value (2018-2029)
4.5 South America Neurological Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Neurological Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Neurological Drugs Sales Quantity by Type (2018-2029)
5.2 Global Neurological Drugs Consumption Value by Type (2018-2029)
5.3 Global Neurological Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neurological Drugs Sales Quantity by Application (2018-2029)
6.2 Global Neurological Drugs Consumption Value by Application (2018-2029)
6.3 Global Neurological Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Neurological Drugs Sales Quantity by Type (2018-2029)
7.2 North America Neurological Drugs Sales Quantity by Application (2018-2029)
7.3 North America Neurological Drugs Market Size by Country
7.3.1 North America Neurological Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Neurological Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Neurological Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Neurological Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Neurological Drugs Market Size by Country
8.3.1 Europe Neurological Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Neurological Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Neurological Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neurological Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neurological Drugs Market Size by Region
9.3.1 Asia-Pacific Neurological Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neurological Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Neurological Drugs Sales Quantity by Type (2018-2029)
10.2 South America Neurological Drugs Sales Quantity by Application (2018-2029)
10.3 South America Neurological Drugs Market Size by Country
10.3.1 South America Neurological Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Neurological Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Neurological Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neurological Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neurological Drugs Market Size by Country
11.3.1 Middle East & Africa Neurological Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neurological Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Neurological Drugs Market Drivers
12.2 Neurological Drugs Market Restraints
12.3 Neurological Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Neurological Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurological Drugs
13.3 Neurological Drugs Production Process
13.4 Neurological Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurological Drugs Typical Distributors
14.3 Neurological Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Neurological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Neurological Drugs Product and Services
Table 6. Pfizer Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Ely Lilly Major Business
Table 10. Ely Lilly Neurological Drugs Product and Services
Table 11. Ely Lilly Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ely Lilly Recent Developments/Updates
Table 13. Actavis Basic Information, Manufacturing Base and Competitors
Table 14. Actavis Major Business
Table 15. Actavis Neurological Drugs Product and Services
Table 16. Actavis Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Actavis Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Neurological Drugs Product and Services
Table 21. Mylan Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Randox Basic Information, Manufacturing Base and Competitors
Table 24. Randox Major Business
Table 25. Randox Neurological Drugs Product and Services
Table 26. Randox Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Randox Recent Developments/Updates
Table 28. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 29. Intellipharmaceutics Major Business
Table 30. Intellipharmaceutics Neurological Drugs Product and Services
Table 31. Intellipharmaceutics Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Intellipharmaceutics Recent Developments/Updates
Table 33. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 34. Astrazeneca Major Business
Table 35. Astrazeneca Neurological Drugs Product and Services
Table 36. Astrazeneca Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Astrazeneca Recent Developments/Updates
Table 38. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 39. Lundbeck Major Business
Table 40. Lundbeck Neurological Drugs Product and Services
Table 41. Lundbeck Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lundbeck Recent Developments/Updates
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Neurological Drugs Product and Services
Table 46. Allergan Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Allergan Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Neurological Drugs Product and Services
Table 51. GSK Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GSK Recent Developments/Updates
Table 53. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Otsuka Pharmaceutical Major Business
Table 55. Otsuka Pharmaceutical Neurological Drugs Product and Services
Table 56. Otsuka Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Otsuka Pharmaceutical Recent Developments/Updates
Table 58. Takeda Basic Information, Manufacturing Base and Competitors
Table 59. Takeda Major Business
Table 60. Takeda Neurological Drugs Product and Services
Table 61. Takeda Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Takeda Recent Developments/Updates
Table 63. NHU Group Basic Information, Manufacturing Base and Competitors
Table 64. NHU Group Major Business
Table 65. NHU Group Neurological Drugs Product and Services
Table 66. NHU Group Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NHU Group Recent Developments/Updates
Table 68. Shionogi Basic Information, Manufacturing Base and Competitors
Table 69. Shionogi Major Business
Table 70. Shionogi Neurological Drugs Product and Services
Table 71. Shionogi Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shionogi Recent Developments/Updates
Table 73. APOTEX Basic Information, Manufacturing Base and Competitors
Table 74. APOTEX Major Business
Table 75. APOTEX Neurological Drugs Product and Services
Table 76. APOTEX Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. APOTEX Recent Developments/Updates
Table 78. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. North China Pharmaceutical Major Business
Table 80. North China Pharmaceutical Neurological Drugs Product and Services
Table 81. North China Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. North China Pharmaceutical Recent Developments/Updates
Table 83. Harbin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Harbin Pharmaceutical Co., Ltd. Major Business
Table 85. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
Table 86. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Lukang Pharmaceutical Major Business
Table 90. Lukang Pharmaceutical Neurological Drugs Product and Services
Table 91. Lukang Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Lukang Pharmaceutical Recent Developments/Updates
Table 93. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Kelun Pharmaceutical Major Business
Table 95. Kelun Pharmaceutical Neurological Drugs Product and Services
Table 96. Kelun Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Kelun Pharmaceutical Recent Developments/Updates
Table 98. Kehua Biology Basic Information, Manufacturing Base and Competitors
Table 99. Kehua Biology Major Business
Table 100. Kehua Biology Neurological Drugs Product and Services
Table 101. Kehua Biology Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Kehua Biology Recent Developments/Updates
Table 103. Global Neurological Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Neurological Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Neurological Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Neurological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Neurological Drugs Production Site of Key Manufacturer
Table 108. Neurological Drugs Market: Company Product Type Footprint
Table 109. Neurological Drugs Market: Company Product Application Footprint
Table 110. Neurological Drugs New Market Entrants and Barriers to Market Entry
Table 111. Neurological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Neurological Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Neurological Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Neurological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Neurological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Neurological Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Neurological Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Neurological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Neurological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Neurological Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Neurological Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Neurological Drugs Raw Material
Table 171. Key Manufacturers of Neurological Drugs Raw Materials
Table 172. Neurological Drugs Typical Distributors
Table 173. Neurological Drugs Typical Customers
Table 1. Global Neurological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Neurological Drugs Product and Services
Table 6. Pfizer Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Ely Lilly Major Business
Table 10. Ely Lilly Neurological Drugs Product and Services
Table 11. Ely Lilly Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ely Lilly Recent Developments/Updates
Table 13. Actavis Basic Information, Manufacturing Base and Competitors
Table 14. Actavis Major Business
Table 15. Actavis Neurological Drugs Product and Services
Table 16. Actavis Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Actavis Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Neurological Drugs Product and Services
Table 21. Mylan Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Randox Basic Information, Manufacturing Base and Competitors
Table 24. Randox Major Business
Table 25. Randox Neurological Drugs Product and Services
Table 26. Randox Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Randox Recent Developments/Updates
Table 28. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 29. Intellipharmaceutics Major Business
Table 30. Intellipharmaceutics Neurological Drugs Product and Services
Table 31. Intellipharmaceutics Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Intellipharmaceutics Recent Developments/Updates
Table 33. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 34. Astrazeneca Major Business
Table 35. Astrazeneca Neurological Drugs Product and Services
Table 36. Astrazeneca Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Astrazeneca Recent Developments/Updates
Table 38. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 39. Lundbeck Major Business
Table 40. Lundbeck Neurological Drugs Product and Services
Table 41. Lundbeck Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lundbeck Recent Developments/Updates
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Neurological Drugs Product and Services
Table 46. Allergan Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Allergan Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Neurological Drugs Product and Services
Table 51. GSK Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GSK Recent Developments/Updates
Table 53. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Otsuka Pharmaceutical Major Business
Table 55. Otsuka Pharmaceutical Neurological Drugs Product and Services
Table 56. Otsuka Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Otsuka Pharmaceutical Recent Developments/Updates
Table 58. Takeda Basic Information, Manufacturing Base and Competitors
Table 59. Takeda Major Business
Table 60. Takeda Neurological Drugs Product and Services
Table 61. Takeda Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Takeda Recent Developments/Updates
Table 63. NHU Group Basic Information, Manufacturing Base and Competitors
Table 64. NHU Group Major Business
Table 65. NHU Group Neurological Drugs Product and Services
Table 66. NHU Group Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NHU Group Recent Developments/Updates
Table 68. Shionogi Basic Information, Manufacturing Base and Competitors
Table 69. Shionogi Major Business
Table 70. Shionogi Neurological Drugs Product and Services
Table 71. Shionogi Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shionogi Recent Developments/Updates
Table 73. APOTEX Basic Information, Manufacturing Base and Competitors
Table 74. APOTEX Major Business
Table 75. APOTEX Neurological Drugs Product and Services
Table 76. APOTEX Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. APOTEX Recent Developments/Updates
Table 78. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. North China Pharmaceutical Major Business
Table 80. North China Pharmaceutical Neurological Drugs Product and Services
Table 81. North China Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. North China Pharmaceutical Recent Developments/Updates
Table 83. Harbin Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Harbin Pharmaceutical Co., Ltd. Major Business
Table 85. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product and Services
Table 86. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Harbin Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Lukang Pharmaceutical Major Business
Table 90. Lukang Pharmaceutical Neurological Drugs Product and Services
Table 91. Lukang Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Lukang Pharmaceutical Recent Developments/Updates
Table 93. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Kelun Pharmaceutical Major Business
Table 95. Kelun Pharmaceutical Neurological Drugs Product and Services
Table 96. Kelun Pharmaceutical Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Kelun Pharmaceutical Recent Developments/Updates
Table 98. Kehua Biology Basic Information, Manufacturing Base and Competitors
Table 99. Kehua Biology Major Business
Table 100. Kehua Biology Neurological Drugs Product and Services
Table 101. Kehua Biology Neurological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Kehua Biology Recent Developments/Updates
Table 103. Global Neurological Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Neurological Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Neurological Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Neurological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Neurological Drugs Production Site of Key Manufacturer
Table 108. Neurological Drugs Market: Company Product Type Footprint
Table 109. Neurological Drugs Market: Company Product Application Footprint
Table 110. Neurological Drugs New Market Entrants and Barriers to Market Entry
Table 111. Neurological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Neurological Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Neurological Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Neurological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Neurological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Neurological Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Neurological Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Neurological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Neurological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Neurological Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Neurological Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Neurological Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Neurological Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Neurological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Neurological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Neurological Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Neurological Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Neurological Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Neurological Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Neurological Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Neurological Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Neurological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Neurological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Neurological Drugs Raw Material
Table 171. Key Manufacturers of Neurological Drugs Raw Materials
Table 172. Neurological Drugs Typical Distributors
Table 173. Neurological Drugs Typical Customers
LIST OF FIGURES
Figure 1. Neurological Drugs Picture
Figure 2. Global Neurological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurological Drugs Consumption Value Market Share by Type in 2022
Figure 4. Non-prescription drugs Examples
Figure 5. Prescription Examples
Figure 6. Global Neurological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Neurological Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Neurological Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Neurological Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Neurological Drugs Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Neurological Drugs Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Neurological Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Neurological Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Neurological Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Neurological Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Neurological Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Neurological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Neurological Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Neurological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Neurological Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 52. China Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Neurological Drugs Market Drivers
Figure 73. Neurological Drugs Market Restraints
Figure 74. Neurological Drugs Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Neurological Drugs in 2022
Figure 77. Manufacturing Process Analysis of Neurological Drugs
Figure 78. Neurological Drugs Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Neurological Drugs Picture
Figure 2. Global Neurological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurological Drugs Consumption Value Market Share by Type in 2022
Figure 4. Non-prescription drugs Examples
Figure 5. Prescription Examples
Figure 6. Global Neurological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Neurological Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Neurological Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Neurological Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Neurological Drugs Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Neurological Drugs Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Neurological Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Neurological Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Neurological Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Neurological Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Neurological Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Neurological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Neurological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Neurological Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Neurological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Neurological Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 52. China Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Neurological Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Neurological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Neurological Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Neurological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Neurological Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Neurological Drugs Market Drivers
Figure 73. Neurological Drugs Market Restraints
Figure 74. Neurological Drugs Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Neurological Drugs in 2022
Figure 77. Manufacturing Process Analysis of Neurological Drugs
Figure 78. Neurological Drugs Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
